Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, China.
Department of Physiology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Sci China Life Sci. 2019 Jan;62(1):46-62. doi: 10.1007/s11427-018-9377-y. Epub 2018 Sep 21.
The prevalence of diabetes has increased dramatically over the past three decades, and currently, China has the largest number of diabetics worldwide; this number continues to grow and puts ongoing strains on the medical resources. In this review, we reviewed the diabetes research conducted in China from 1995 to 2015 with the aim of providing new insights regarding the current status and future perspectives for researchers, diabetes health providers, and respective policy-makers. Remarkable progress has been made in diabetes research in China during the past two decades in terms of both the quantity and publication influence. The progress, however, struggles to adequately manage diabetes in China. Here we addressed opportunities to strengthen researches, including new drug development, high quality studies on health economics, and healthcare quality improvement studies. As the expected wave of diabetic complications is upcoming and overwhelming, we therefore recommend that immediate improvements are required to implement the researches regarding their prevention and treatment.
在过去的三十年中,糖尿病的患病率急剧上升,目前中国拥有全球最多的糖尿病患者;这个数字还在不断增长,给医疗资源带来持续的压力。在本次综述中,我们回顾了 1995 年至 2015 年期间在中国开展的糖尿病研究,旨在为研究人员、糖尿病健康提供者和相关政策制定者提供当前状况和未来展望的新见解。在过去的二十年中,中国在糖尿病研究方面取得了显著的进展,无论是在数量还是在出版影响力方面。然而,这一进展难以充分应对中国的糖尿病问题。在这里,我们探讨了加强研究的机会,包括新药开发、健康经济学高质量研究以及医疗保健质量改进研究。随着预期的糖尿病并发症浪潮即将到来并势不可挡,我们因此建议需要立即改进实施预防和治疗相关研究。